• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% studentrabatt med kod TERM26

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Sjukdomar och rubbningar
    4. Onkologi

    Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies

    AvManmohan Singh,Maya Salnikova

    Inbunden, Engelska, 2015

    2 022 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel approaches to the treatment of cancer, immunotherapy and more. It includes real-world cases and examples which highlight formulations with therapeutic proteins, monoclonal antibodies, peptides and biobetters, as well as cases on novel vaccines formulations including evolving pathogens, novel modalities of vaccines, universal vaccines. This book is a thorough and useful resource on the development of novel biologics, vaccines and cancer therapies.

    • Provides strategies for the development of safe and efficacious novel formulations for various modalities of biologics, vaccines and for cancer therapy
    • Highlights novel cases from current clinical trials as well as marketed products
    • Reviews overall successes and challenges in the development of novel formulations, including new molecular targets for the treatment of diseases, design of target-specific therapies, regulatory considerations, individualized therapies

    Produktinformation

    • Utgivningsdatum:2015-01-05
    • Mått:191 x 235 x 27 mm
    • Vikt:1 370 g
    • Format:Inbunden
    • Språk:Engelska
    • Antal sidor:520
    • Förlag:Elsevier Science
    • ISBN:9780124166035

    Utforska kategorier

    • Onkologi inom Medicin
    • Farmakologi inom Medicin

    Mer om författaren

    Manmohan Singh, Ph.D. is a well-known expert in the area of vaccine formulations and adjuvant research and has been working in vaccine R&D for the last 20 years. He has authored over 120 peer reviewed manuscripts, review articles and book chapters in this area. Dr. Singh is on the editorial board of 9 International Journals . He is also the editor of several books on vaccine delivery systems and adjuvants. He is currently working as the Head of Global Drug Product Development at Novartis Vaccines in Holly Springs, NC, U.S.A. Maya Salnikova, Ph.D. is a well-known expert in the area of biologics, biosimilars and vaccine formulations. She has been working on development of novel formulations for the past 10 years in academia and industry. She has authored over 20 peer reviewed articles and book chapters. Dr. Salnikova is on the board of reviewers for Journal of Pharmaceutical Sciences and has contributed in organizing of international conferences. She is currently working as Drug Product Development Lead at Novartis Vaccines in Holly Springs, NC, U.S.A.

    Innehållsförteckning

    • Section I: NOVEL THERAPEUTIC APPROACHES1. Clinical Considerations in the Design, Evaluation and Development of Novel Therapies2. New Era in Gene Therapy3. Advances in Nanotechnology-Based Drug Delivery Platforms and Novel Drug Delivery Systems4. Novel Approaches for the Delivery of Biologics to the Central Nervous System5. Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer TherapiesSection II: NOVEL APPROACHES FOR BIOLOGICS6. Novel Generation of Antibody-Based Therapeutics7. Novel Approaches in Discovery and Design of Antibody-Based Therapeutics8. Novel Therapeutic Proteins and Peptides9. Biobetter BiologicsSection III: NOVEL APPROACHES FOR VACCINES10. Vaccines Against Non-Infectious, Non-Cancer Novel Targets11. Winning a Race Against Evolving Pathogens with Novel Platforms and Universal Vaccines12. Prime-Boost Vaccination: Impact on the HIV Vaccine FieldSection IV: NOVEL APPROACHES FOR CANCER THERAPIESIV.I Novel Therapeutic Approaches and Targets for Cancer13. Personalized Therapies for Cancer Treatment14. Hunting Molecular Targets for Anticancer Reagents by Chemical ProteomicsIV.II Novel Immunotherapies for Cancer15. Cancer Vaccines16. T-Cell Immunotherapy for Cancer17. Immunostimulators and Immunomodulators in Cancer TreatmentIV.III Novel Approaches for Cancer Therapy with Small Molecules18. Long-Circulating Therapies for Cancer Treatment19. Recent Advances and Trends in the Brain Delivery of Small Molecule Based Cancer Therapies